BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12031672)

  • 41. The 11S regulators of 20S proteasome activity.
    Hill CP; Masters EI; Whitby FG
    Curr Top Microbiol Immunol; 2002; 268():73-89. PubMed ID: 12083009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors.
    Nazif T; Bogyo M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2967-72. PubMed ID: 11248015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core.
    Heinemeyer W; Ramos PC; Dohmen RJ
    Cell Mol Life Sci; 2004 Jul; 61(13):1562-78. PubMed ID: 15224181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
    Demasi M; Shringarpure R; Davies KJ
    Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution.
    Löwe J; Stock D; Jap B; Zwickl P; Baumeister W; Huber R
    Science; 1995 Apr; 268(5210):533-9. PubMed ID: 7725097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo and in vitro phosphorylation of Candida albicans 20S proteasome.
    Fernández Murray P; Pardo PS; Zelada AM; Passeron S
    Arch Biochem Biophys; 2002 Aug; 404(1):116-25. PubMed ID: 12127076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and functions of the 20S and 26S proteasomes.
    Coux O; Tanaka K; Goldberg AL
    Annu Rev Biochem; 1996; 65():801-47. PubMed ID: 8811196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of two 20S proteasomes from the endoplasmic reticulum of rat liver microsomes.
    Hori H; Nembai T; Miyata Y; Hayashi T; Ueno K; Koide T
    J Biochem; 1999 Oct; 126(4):722-30. PubMed ID: 10502681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.
    Li J; Gao X; Ortega J; Nazif T; Joss L; Bogyo M; Steven AC; Rechsteiner M
    EMBO J; 2001 Jul; 20(13):3359-69. PubMed ID: 11432824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.
    Nussbaum AK; Dick TP; Keilholz W; Schirle M; Stevanović S; Dietz K; Heinemeyer W; Groll M; Wolf DH; Huber R; Rammensee HG; Schild H
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12504-9. PubMed ID: 9770515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arecoline tripeptide inhibitors of proteasome.
    Marastoni M; Baldisserotto A; Canella A; Gavioli R; Risi CD; Pollini GP; Tomatis R
    J Med Chem; 2004 Mar; 47(6):1587-90. PubMed ID: 14998343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decelerated degradation of short peptides by the 20S proteasome.
    Dolenc I; Seemüller E; Baumeister W
    FEBS Lett; 1998 Sep; 434(3):357-61. PubMed ID: 9742954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pore of activated 20S proteasomes has an ordered 7-fold symmetric conformation.
    Förster A; Whitby FG; Hill CP
    EMBO J; 2003 Sep; 22(17):4356-64. PubMed ID: 12941688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The proteasome activator 11 S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits.
    Li J; Gao X; Joss L; Rechsteiner M
    J Mol Biol; 2000 Jun; 299(3):641-54. PubMed ID: 10835274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell biology: unchaining the condemned.
    Wilkinson KD
    Nature; 2002 Sep; 419(6905):351-3. PubMed ID: 12353019
    [No Abstract]   [Full Text] [Related]  

  • 56. Crystal structure of HslUV complexed with a vinyl sulfone inhibitor: corroboration of a proposed mechanism of allosteric activation of HslV by HslU.
    Sousa MC; Kessler BM; Overkleeft HS; McKay DB
    J Mol Biol; 2002 May; 318(3):779-85. PubMed ID: 12054822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identical subunit topographies of human and yeast 20S proteasomes.
    Dahlmann B; Kopp F; Kristensen P; Hendil KB
    Arch Biochem Biophys; 1999 Mar; 363(2):296-300. PubMed ID: 10068451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subunit arrangement in the human 20S proteasome.
    Kopp F; Hendil KB; Dahlmann B; Kristensen P; Sobek A; Uerkvitz W
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2939-44. PubMed ID: 9096325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure determination of the constitutive 20S proteasome from bovine liver at 2.75 A resolution.
    Unno M; Mizushima T; Morimoto Y; Tomisugi Y; Tanaka K; Yasuoka N; Tsukihara T
    J Biochem; 2002 Feb; 131(2):171-3. PubMed ID: 11820928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.
    Kaiser M; Groll M; Renner C; Huber R; Moroder L
    Angew Chem Int Ed Engl; 2002 Mar; 41(5):780-3. PubMed ID: 12491334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.